Study reveals AI insights can predict development of disease a decade in advance
The study predicted the development of conditions including Alzheimer’s and heart disease
Read More
Tag: heart disease
Four international teams awarded £4.7m to investigate heart and circulatory diseases
These types of conditions are responsible for 25% of all UK deaths and affect 7.6 million people nationally
Read More
Reusable ECGI vest successfully detects early signs of inherited hypertrophic cardiomyopathy
The inherited fatal heart muscle condition affects one in every 500 adults in the UK
Read More
People with chest pain more likely to develop heart and circulatory diseases
Around one million adults in the UK visit their GP every year due to chest pain
Read More
BHF data reveals early heart disease deaths rise to highest level
In 2022, over 39,000 people in England died prematurely of cardiovascular conditions
Read More
Scientists to rewrite DNA in search for heart disease cure
The British Heart Foundation’s ‘Big Beat Challenge’ grant of £30m for research into cardiovascular medicine was given to CureHeart
Read More
Abbott’s AI-powered coronary imaging platform deployed in the UK
Heart attack patients offered treatment with new technology at the Royal Free Hospital in London
Read More
MHRA authorises Amarin’s heart drug Vazkepa
Drug demonstrated a 25% relative risk reduction in the first occurrence of major adverse cardiovascular events in REDUCE-IT trial
Read More
New US approval for AZ’ Brilinta
New Brilinta indication expands treatment to high-risk coronary patients without a history of stroke or heart attack
Read More
NHS to review making statins available for pharmacists
If only 45% of people with a high risk of cardiovascular disease were identified and treated, 6,000 strokes and heart attacks could be avoided over the next ten years.
Read More
NHS to roll out high street heart checks
Cardiovascular disease costs the NHS £7 billion a year.
Read More
Sanofi and MyoKardia end heart disease drug collaboration
Bringing an end to a four-year partnership, Sanofi has terminated its agreement with MyoKardia to jointly develop small-molecule therapeutics, targeting genetic mutations associated with certain heart diseases.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
